HCM |
hypertrophic cardiomyopathy |
CMI |
cardiac myosin inhibitors |
LVOT |
left ventricular outflow tract |
oHCM |
obstructive hypertrophic cardiomyopathy |
nHCM |
non-obstructive hypertrophic cardiomyopathy |
ATP |
adenosine triphosphate |
LVEF |
left ventricular ejection fraction |
NYHA |
New York Heart Association |
ECG |
electrocardiography |
KCCQ-CSS |
Kansas City Cardiomyopathy Questionnaire Clinical Summary Score |
HCMSQ-SoB |
Hypertrophic Cardiomyopathy Symptom Questionnaire Shortness-of-Breath sub-score |
HFpEF |
heart failure with preserved ejection fraction |
FDA |
Food and Drug Administration |
EMA |
European Medicines Agency |